• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-羧基四氢喹啉。NMDA受体甘氨酸位点拮抗作用的构象和立体化学要求。

2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the NMDA receptor.

作者信息

Carling R W, Leeson P D, Moseley A M, Baker R, Foster A C, Grimwood S, Kemp J A, Marshall G R

机构信息

Department of Medicinal Chemistry, Merck Sharp and Dohme Research Laboratories, Harlow, Essex, UK.

出版信息

J Med Chem. 1992 May 29;35(11):1942-53. doi: 10.1021/jm00089a003.

DOI:10.1021/jm00089a003
PMID:1534583
Abstract

2-Carboxy-1,2,3,4-tetrahydroquinoline derivatives, derived from kynurenic acid, have been synthesized and evaluated for in vitro antagonist activity at the glycine site on the NMDA receptor. 2,3-Dihydrokynurenic acids show reduced potency relative to the parent lead compounds (Table I) possibly as a result of conformational effects. Removal of the 4-oxo group results in further reduced potency, but introduction of a cis-carboxymethyl group to the 4-position restores antagonist activity (Tables III and IV). Replacement of the keto group of 5,7-dichloro-2,3-dihydrokynurenic acid with other alternative H-bonding groups, for example cis- and trans-benzyloxycarbonyl and cis- and trans-carboxamido (Table V), gives comparable activity, but there is negligible stereoselectivity. A significant increase in potency and stereoselectivity is seen within the 4-acetate series (Table VI). The trans-4-acetic acid is significantly more potent than the corresponding lead kynurenic acid and has 100-fold greater affinity than the cis isomer. The results are consistent with a requirement in binding for a pseudoequatorially placed 2-carboxylate and clearly demonstrate the importance for binding of a correctly positioned hydrogen-bond-accepting group at the 4-position. The high-affinity binding of an anionic group in the 4-substituent binding pocket suggests that the glycine site and the neurotransmitter recognition (NMDA) site may have some features in common.

摘要

源自犬尿喹啉酸的2-羧基-1,2,3,4-四氢喹啉衍生物已被合成,并对其在NMDA受体甘氨酸位点的体外拮抗活性进行了评估。与母体先导化合物相比,2,3-二氢犬尿喹啉酸的效力降低(表I),这可能是构象效应的结果。去除4-氧代基团会导致效力进一步降低,但在4位引入顺式羧甲基基团可恢复拮抗活性(表III和IV)。用其他替代氢键基团取代5,7-二氯-2,3-二氢犬尿喹啉酸的酮基,例如顺式和反式苄氧羰基以及顺式和反式羧酰胺(表V),可得到相当的活性,但立体选择性可忽略不计。在4-乙酸酯系列中观察到效力和立体选择性显著增加(表VI)。反式-4-乙酸的效力明显高于相应的先导犬尿喹啉酸,其亲和力比顺式异构体高100倍。结果与结合时对假赤道位置的2-羧酸盐的要求一致,并清楚地证明了在4位正确定位的氢键接受基团对结合的重要性。4-取代基结合口袋中阴离子基团的高亲和力结合表明,甘氨酸位点和神经递质识别(NMDA)位点可能有一些共同特征。

相似文献

1
2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the NMDA receptor.2-羧基四氢喹啉。NMDA受体甘氨酸位点拮抗作用的构象和立体化学要求。
J Med Chem. 1992 May 29;35(11):1942-53. doi: 10.1021/jm00089a003.
2
4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.4-氨基-2-羧基四氢喹啉。NMDA受体甘氨酸位点拮抗作用的构效关系。
J Med Chem. 1992 May 29;35(11):1954-68. doi: 10.1021/jm00089a004.
3
Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.1,2,3,4-四氢喹啉-2,3,4-三酮3-肟的合成及其构效关系:新型高效的N-甲基-D-天冬氨酸受体甘氨酸位点拮抗剂
J Med Chem. 1996 Aug 16;39(17):3248-55. doi: 10.1021/jm960214k.
4
Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.对大鼠脑N-甲基-D-天冬氨酸受体甘氨酸位点具有更高亲和力和选择性的犬尿氨酸类似物。
Mol Pharmacol. 1992 May;41(5):914-22.
5
Thiokynurenates: a new group of antagonists of the glycine modulatory site of the NMDA receptor.硫代犬尿氨酸盐:一类新型N-甲基-D-天冬氨酸受体甘氨酸调节位点拮抗剂。
Eur J Pharmacol. 1991 Jun 25;199(2):227-32. doi: 10.1016/0014-2999(91)90461-x.
6
A novel series of 2-carboxytetrahydroquinolines provides new insights into the eastern region of glycine site NMDA antagonists.一系列新型的2-羧基四氢喹啉为甘氨酸位点N-甲基-D-天冬氨酸拮抗剂的东部区域提供了新的见解。
Arch Pharm (Weinheim). 2000 Aug;333(8):267-74. doi: 10.1002/1521-4184(20008)333:8<267::aid-ardp267>3.0.co;2-0.
7
Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor.犬尿喹啉酸衍生物。兴奋性氨基酸拮抗作用的构效关系以及N-甲基-D-天冬氨酸受体甘氨酸位点强效和选择性拮抗剂的鉴定。
J Med Chem. 1991 Apr;34(4):1243-52. doi: 10.1021/jm00108a002.
8
4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.4-取代-3-苯基喹啉-2(1H)-酮:具有体内活性的酸性和非酸性甘氨酸位点N-甲基-D-天冬氨酸拮抗剂。
J Med Chem. 1997 Feb 28;40(5):754-65. doi: 10.1021/jm9605492.
9
Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.烷基和烷氧基取代的1,4 - 二氢喹喔啉 - 2,3 - 二酮的构效关系:NMDA受体甘氨酸位点的强效且具有全身活性的拮抗剂
J Med Chem. 1997 Feb 28;40(5):730-8. doi: 10.1021/jm960654b.
10
Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
J Med Chem. 1996 Nov 8;39(23):4643-53. doi: 10.1021/jm960479z.

引用本文的文献

1
Does kynurenic acid act on nicotinic receptors? An assessment of the evidence.犬尿酸是否作用于烟碱型受体?证据评估。
J Neurochem. 2020 Mar;152(6):627-649. doi: 10.1111/jnc.14907. Epub 2019 Nov 24.
2
1MeTIQ provides protection against Aβ-induced reduction of surface expression of synaptic proteins and inhibits H₂O₂-induced oxidative stress in primary hippocampal neurons.1MeTIQ可防止Aβ诱导的突触蛋白表面表达减少,并抑制原代海马神经元中H₂O₂诱导的氧化应激。
Neurotox Res. 2014 May;25(4):348-57. doi: 10.1007/s12640-013-9440-1. Epub 2013 Nov 20.
3
Possible NMDA antagonist properties of drugs that affect high pressure neurological syndrome.
影响高压神经综合征的药物可能具有的N-甲基-D-天冬氨酸(NMDA)拮抗剂特性。
Br J Pharmacol. 1994 Mar;111(3):951-5. doi: 10.1111/j.1476-5381.1994.tb14831.x.